Randomized trial of rATg/Daclizumab vs. rATg/Alemtuzumab as dual induction therapy in renal transplantation: Results at 8years of follow-up
Author:
Publisher
Elsevier BV
Subject
Transplantation,Immunology,Immunology and Allergy
Reference61 articles.
1. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year;Ciancio;Transplantation,2004
2. A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1year;Ciancio;Transplantation,2004
3. A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate versus cyclosporine/sirolimus in renal transplantation: three-year analysis;Ciancio;Transplantation,2006
4. Randomized trial of immunosuppressive regimens in renal transplantation;Guerra;J. Am. Soc. Nephrol.,2011
5. A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring;Ciancio;Transplantation,2005
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Venous vascular reconstruction of a robotically procured right kidney with two renal veins transplanted into a pediatric recipient;Pediatric Transplantation;2023-11-17
2. Donor Bone Marrow Conditioning, Chimerism, and Tolerance Induction;Transplantation of the Pancreas;2023
3. Predictors of Kidney Delayed Graft Function and Its Prognostic Impact following Combined Liver–Kidney Transplantation: A Recent Single-Center Experience;Journal of Clinical Medicine;2022-05-11
4. Creating a Single Inflow Orifice From Living Donor Kidney Allografts With Multiple Renal Arteries;Transplant International;2022-04-14
5. Lymphoproliferative Diseases;Atlas of Dermatologic Diseases in Solid Organ Transplant Recipients;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3